Showing results (81-90 of 222) with videos related to
Sort By:
Pageof 23
Blood Advances|August 19, 2025
KDIGO-Defined Kidney Dysfunction Predicts Long-Term Outcomes in a Multi-Center Cohort of Adults with Sickle Cell DiseaseXu Zhang, Michael R DeBaun, Kristin Wuichet, et al.Clinical Lymphoma, Myeloma & Leukemia|April 8, 2016
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative NeoplasmsIrum Khan, Ardaman Shergill, Santosh L Saraf, et al.Frontiers in Physiology|April 3, 2023
Metabolic correlates to critical speed in murine models of sickle cell diseaseFrancesca I Cendali, Travis Nemkov, Christina Lisk, et al.Blood Cells, Molecules & Diseases|May 4, 2002
Endemic polycythemia in Russia: mutation in the VHL geneSonny O Ang, Hua Chen, Victor R Gordeuk, et al.Haematologica|October 21, 2016
ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell diseaseKyungho Kim, Jing Li, Andrew Barazia, et al.British Journal of Haematology|April 23, 2010
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaZakari Y Aliyu, Aisha Suleiman, Ester Attah, et al.Haematologica|October 16, 2012
Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidinSergei Nekhai, Min Xu, Altreisha Foster, et al.American Journal of Hematology|February 10, 2022
Pregnancy outcomes with hydroxyurea use in women with sickle cell diseaseBarbara L Kroner, Jane S Hankins, Norma Pugh, et al.Journal of Tropical Diseases & Public Health|November 10, 2018
Sickle Cell Disease Clinical Trials and PhenotypesChinedu A Ezekekwu, Taiwo R Kotila, Titilola S Akingbola, et al.Proteomics. Clinical Applications|August 11, 2025
Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation VelocityVarshini Babu, Jane A Little, Claudia R Morris, et al.Pageof 23